Becker SL, Fusco JS, Justice AC, Hansen NI, Fusco GP. Comparison of protease inhibitor (PI)-containing and non-nucleoside reverse transcriptase inhibitor (NNRTI)-containing HAART in HIV patients naïve to antiretrovirals. Poster 230. International AIDS Society Conference on HIV Pathogenesis and Treatment. July 8 –11, 2001, Buenos Aires, Argentina
Research Category: Abstracts and Posters
Cross-resistance to amprenavir and lopinavir in HIV-1 from subjects failing protease inhibitor therapies; mutations in HIV-1 with resistance to one or both drugs
Paulsen D, Shaefer M, Fusco GP, Ross L. Cross-resistance to amprenavir and lopinavir in HIV-1 from subjects failing protease inhibitor therapies; mutations in HIV-1 with resistance to one or both drugs. Poster. 5th International Workshop on HIV Drug Resistance & Treatment Strategies. June 4-8, 2001, Scottsdale, AZ
Strategies for obtaining consistent diagnoses for cause of death in an observational cohort study
Justice AC, Fusco JS, Becker SL, Raffanti SR, Fusco GP. Strategies for obtaining consistent diagnoses for cause of death in an observational cohort study. Poster. 5th International Workshop on HIV Observational Databases. April 2001, Monte Carlo, Monaco
Predictors of lipodystrophy in HIV-infected patients
Scarsella AJ, Dieterich DT, Graham NMH, Fusco GP, Sherrill BH, Fusco JS, Hansen NI, Becker SL. Predictors of lipodystrophy in HIV-infected patients. Poster. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2000, Toronto, Ontario
Efficacy of amprenavir-containing HAART regimens in protease inhibitor-experienced patients
Becker SL, Scarsella A, Graham N, Fusco GP, Sherrill B, Fusco JS, Hansen N. Efficacy of amprenavir-containing HAART regimens in protease inhibitor-experienced patients. Poster. 38th Annual Meeting of the Infectious Disease Society of America (IDSA). September 2000, New Orleans, LA
Comparative effects on clinical progression of d4T vs. ZDV containing regimens
Justice AC, Stein DS, Fusco GP, Sherrill BH, Danehower SC, Fusco JS, Hansen NI, Becker SL. Comparative effects on clinical progression of d4T vs. ZDV containing regimens. Poster. 7th Conference on Retroviruses and Opportunistic Infections. January-February 2000, San Francisco, CA
Relationships among antiretroviral therapies (ART) and clinical outcomes
Justice A, Stein DS, Fusco GP, Sherrill B, Danehower S, Fusco J, Hansen N, Becker S. Relationships among antiretroviral therapies (ART) and clinical outcomes. Poster. 7th Conference on Retroviruses and Opportunistic Infections. January-February 2000, San Francisco, CA
The effect of virologic control on rates of disease progression
Raffanti SR, Fusco GP, Mangialardi WJ, Fusco JS, Hansen NI, Sherrill BH, Igboko EF. The effect of virologic control on rates of disease progression. Poster. 37th Annual Meeting of the Infectious Disease Society of America (IDSA). November 1999, Philadelphia, PA